From Our Partners
Friday, June 24, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

Ricin Vaccine Performs Well in Tulane Study

by Global Biodefense Staff
November 10, 2014
Biodefense Vaccine Development

Credit: Shutterstock, modified by Global Biodefense

A recent study at the Tulane National Primate Research Center showed for the first time that an experimental vaccine could completely protect nonhuman primates exposed to deadly ricin toxin, a potential bioterrorism agent.

Chad Roy, Director of Infectious Disease Aerobiology at the Tulane National Primate Research Center, led the proof-of-concept study.

The research is an important step in establishing the efficacy of a vaccine that could be a key biodefense product for those in the military, law enforcement or first responders who would potentially be at risk for exposure, Roy says.

“This is potentially a game-changer. This is the first time anyone has demonstrated complete protection with a vaccine against ricin toxin in this advanced of an animal model,” said Roy. “Although the vaccine has a considerable way to go for FDA licensure, we have demonstrated through our studies that we can effectively vaccinate to protect against one of the most notorious biological toxins.”

Soligenix is developing the vaccine, called RiVax. The pilot study, which was funded by the National Institutes of Health, was conducted with researchers from the University of Kansas, University of Texas Southwestern Medical School, University of Colorado and the New York State Department of Health.

Source: Tulane National Primate Research Center, adapted.

From Our Partners
Tags: Animal ModelsBioterrorismRicinVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America
Infectious Diseases

Chronic Wasting Disease: The Fatal Prion Infection Killing Elk and Deer in North America

June 10, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC